Literature DB >> 16650683

Ocular hypertension and secondary glaucoma in children with uveitis.

Karen M Sijssens1, Aniki Rothova, Tos T J M Berendschot, Joke H de Boer.   

Abstract

PURPOSE: To identify the risk factors for ocular hypertension and secondary glaucoma in children with uveitis.
DESIGN: Retrospective observational case series of 147 patient records. PARTICIPANTS: Two hundred fifty-six eyes of 147 children with uveitis diagnosed before the age of 16 years.
METHODS: Data were obtained from the medical records of children with uveitis evaluated at our institute from 1990 through 2004. MAIN OUTCOME MEASURES: Localization and course of uveitis (acute or chronic), underlying systemic disease, onset of ocular hypertension, onset of secondary glaucoma, treatment with steroids, antinuclear antibodies (ANAs), lens extractions, number of blind eyes at onset and during follow-up, and the duration of follow-up.
RESULTS: Elevated intraocular pressure developed in 35% of children with pediatric uveitis regardless of the form or type of uveitis during a follow-up of 5 years. Secondary glaucoma, however, developed more frequently in juvenile idiopathic arthritis-associated uveitis (38%) compared with other forms of uveitis (11%) and more frequently in children with uveitis who were ANA positive (42%) than in those who were ANA negative (6%). Elevated intraocular pressure occurred in two thirds of all children within the first 2 years after the diagnosis of uveitis. Except for patients with juvenile idiopathic arthritis-associated uveitis, periocular steroid injections represented an additional risk factor for secondary glaucoma, but this risk was limited to the early phase of the disease process.
CONCLUSIONS: In children with uveitis in this series, juvenile idiopathic arthritis-associated uveitis and ANA-positive uveitis without evidence of arthritis are the most important risk factors for developing secondary glaucoma.

Entities:  

Mesh:

Year:  2006        PMID: 16650683     DOI: 10.1016/j.ophtha.2006.01.043

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

Review 1.  [Uveitis in juvenile idiopathic arthritis].

Authors:  C Heinz; A Heiligenhaus; J Kümmerle-Deschner; I Foeldvari
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

Review 2.  Uveitis in juvenile idiopathic arthritis.

Authors:  Arnd Heiligenhaus; Kirsten Minden; Dirk Föll; Uwe Pleyer
Journal:  Dtsch Arztebl Int       Date:  2015-02-06       Impact factor: 5.594

Review 3.  Non-infectious pediatric uveitis: an update on immunomodulatory management.

Authors:  Srilakshmi M Sharma; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

4.  Juvenile idiopathic arthritis-associated uveitis: Data from a region in western Greece.

Authors:  Ioannis Asproudis; Taxiarchis Felekis; Elena Tsanou; Spiridon Gorezis; Eikaterini Karali; Sapfo Alfantaki; Antigoni Siamopoulou-Mauridou; Miltiadis Aspiotis
Journal:  Clin Ophthalmol       Date:  2010-04-26

5.  A reconsideration of anterior chamber flare and its clinical relevance for children with chronic anterior uveitis (an American Ophthalmological Society thesis).

Authors:  Gary N Holland
Journal:  Trans Am Ophthalmol Soc       Date:  2007

6.  Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis.

Authors:  Marc Breitbach; Christoph Tappeiner; Michael R R Böhm; Beatrix Zurek-Imhoff; Carsten Heinz; Solon Thanos; Gerd Ganser; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-30       Impact factor: 3.117

Review 7.  [Secondary glaucoma in childhood uveitis].

Authors:  C Heinz; U Pleyer; P Ruokonnen; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

Review 8.  [Intraocular pressure related to uveitis].

Authors:  U Pleyer; P Ruokonen; C Heinz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

9.  Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy.

Authors:  I Castagna; A M Roszkowska; F Alessandrello; G W Oliverio; G Tumminello; R Gallizzi; G Conti; P Aragona
Journal:  Int Ophthalmol       Date:  2019-10-04       Impact factor: 2.031

10.  Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.

Authors:  Francesco Pichi; Paolo Nucci; Kimberly Baynes; Careen Y Lowder; Sunil K Srivastava
Journal:  Int Ophthalmol       Date:  2016-05-24       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.